New master trial aims to match immunotherapy to each Patient's tumor before surgery
NCT ID NCT07262489
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests giving immunotherapy before surgery for cancers that haven't spread. It uses a rapid blood and tumor test to match each patient to the treatment most likely to work for them. The goal is to shrink tumors, boost the immune system, and lower the chance of cancer coming back. About 200 people will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED CANCER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gustave Roussy
RECRUITINGVillejuif, 94800, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.